| Kevin P Morgan, MD | |
|
1012 E 2nd St, Duluth, MN 55805-2200 | |
| (218) 249-7870 | |
| Not Available |
| Full Name | Kevin P Morgan |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1012 E 2nd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184877904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 57-015033 (Ohio) | Secondary |
| 208000000X | Pediatrics | 55500 (Wisconsin) | Secondary |
| 208000000X | Pediatrics | 57271 (Minnesota) | Primary |
| Entity Name | Range Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669569265 PECOS PAC ID: 8022920024 Enrollment ID: O20031110000095 |
News Archive
Tomorrow on World Alzheimer's Day, the Alzheimer's Association recognizes the efforts of the Obama Administration for bringing stakeholders to the table to begin an important dialogue on how best to address the Alzheimer epidemic. The meeting will include representatives of the Alzheimer community, policymakers from across the federal government, Alzheimer researchers, people with Alzheimer's and care providers to exchange objectives and strategies on how to overcome the growing Alzheimer epidemic.
Scientists at Melbourne's Howard Florey Institute have developed a cost-effective diagnostic test for Parkinson's disease (PD), which will also assist researchers to understand the genetic basis of PD and to undertake large-scale studies to identify the genes that cause this debilitating condition.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
Greg A. Sachs, M.D., has received an award from the National Palliative Care Research Center to conduct a study aimed at improving quality of life and decreasing suffering for older adults and their family caregivers. The award is one of only two pilot project support grants funded by NPCRC in 2008.
› Verified 8 days ago
| Entity Name | St Lukes Hospital Of Duluth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902845068 PECOS PAC ID: 7113834839 Enrollment ID: O20031120000212 |
News Archive
Tomorrow on World Alzheimer's Day, the Alzheimer's Association recognizes the efforts of the Obama Administration for bringing stakeholders to the table to begin an important dialogue on how best to address the Alzheimer epidemic. The meeting will include representatives of the Alzheimer community, policymakers from across the federal government, Alzheimer researchers, people with Alzheimer's and care providers to exchange objectives and strategies on how to overcome the growing Alzheimer epidemic.
Scientists at Melbourne's Howard Florey Institute have developed a cost-effective diagnostic test for Parkinson's disease (PD), which will also assist researchers to understand the genetic basis of PD and to undertake large-scale studies to identify the genes that cause this debilitating condition.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
Greg A. Sachs, M.D., has received an award from the National Palliative Care Research Center to conduct a study aimed at improving quality of life and decreasing suffering for older adults and their family caregivers. The award is one of only two pilot project support grants funded by NPCRC in 2008.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin P Morgan, MD 1012 E 2nd St, Duluth, MN 55805-2200 Ph: (218) 249-7870 | Kevin P Morgan, MD 1012 E 2nd St, Duluth, MN 55805-2200 Ph: (218) 249-7870 |
News Archive
Tomorrow on World Alzheimer's Day, the Alzheimer's Association recognizes the efforts of the Obama Administration for bringing stakeholders to the table to begin an important dialogue on how best to address the Alzheimer epidemic. The meeting will include representatives of the Alzheimer community, policymakers from across the federal government, Alzheimer researchers, people with Alzheimer's and care providers to exchange objectives and strategies on how to overcome the growing Alzheimer epidemic.
Scientists at Melbourne's Howard Florey Institute have developed a cost-effective diagnostic test for Parkinson's disease (PD), which will also assist researchers to understand the genetic basis of PD and to undertake large-scale studies to identify the genes that cause this debilitating condition.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
Greg A. Sachs, M.D., has received an award from the National Palliative Care Research Center to conduct a study aimed at improving quality of life and decreasing suffering for older adults and their family caregivers. The award is one of only two pilot project support grants funded by NPCRC in 2008.
› Verified 8 days ago
Michael Albert Bronson, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-3400 | |
Nancy Joyce Dronen, Pediatrics Medicare: Medicare Enrolled Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-3400 | |
Megan Browning Baldes, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Gabrielle Zimbric Hester, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5555 | |
Dr. Sarah M Frenning, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 420 E 1st St, Duluth, MN 55805 Phone: 218-786-8364 | |
Jerome Edward Kwako, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Ross William Perko, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 |